RESEARCH TRIANGLE PARK, N.C. — Metabolon is rolling out a new drug discovery product designed to help drug companies monitor the effects of drugs on humans in clinical trials.

The mProveClinical service monitors the biochemical and physiological effects of drug candidates with the intent of helping companies make more informed decisions about drug candidates. Metabolon said.

Metabolon has developed patent-pending technology around metabolomics (an approach to identifying biomarkers) that it says will “dramatically impact drug discovery and development processes.”